ClinicalTrials.gov
ClinicalTrials.gov Menu

Examining Parkinson's Disease-Related Retirement: Results of Turkey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03779880
Recruitment Status : Active, not recruiting
First Posted : December 19, 2018
Last Update Posted : January 10, 2019
Sponsor:
Collaborators:
Marmara University
Istanbul University
Information provided by (Responsible Party):
Gamze Ertürk, Istanbul Kültür University

Brief Summary:
Although Parkinson Disease's (PD) is usually associated with an older patient population, 5% of patients are diagnosed at age 50 and 30% before 65 years of age. This shows that many patients with PD have diagnosed during the active study and have long periods of normal retirement. After the diagnosis of Parkinson's patients, the duration of leaving of employment vary between 0 and 25 years. It was found that patients' full-time working capacity decreased by up to 80% and they quitted earlier than the general population. The disability associated with PD is thought to be a factor in this situation. Nevertheless, the reasons for early retirement are not fully known and more information is needed on the specific problems of PD in order for patients to continue their career. The aim of our study is to examine the impact of Parkinson's disease on retirement and to contribute to Turkey's data. Patients with PD admitted to the Parkinson's disease outpatient clinic, which is the biggest clinic of Turkey about neurology, are included in the study. It is planned to meet with 75 patients on 31/12/2018 and to reach the end of the data collection phase.

Condition or disease
Parkinson Disease

Study Type : Observational
Actual Enrollment : 75 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Examining Parkinson's Disease-Related Retirement: Results of Turkey
Actual Study Start Date : May 2, 2018
Actual Primary Completion Date : December 31, 2018
Estimated Study Completion Date : February 28, 2019

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Qualitative interview [ Time Frame: The researcher interviewed for about half an hour at once time with each participant. ]
    The researcher conducted interviews to find out about things that could not be directly observed. Interviews have been done face to face and used to collect personal experiences about Parkinson Disease and work life.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants were chosen from among retired Parkinson's patients who met the inclusion criteria and are applied Istanbul Cerrahpaşa University, has largest movement disorders unit of Turkey, between May and December 2018.
Criteria

Inclusion Criteria:

  • To be between 30-85 aged
  • Parkinson Disease diagnosis according to the United Kingdom Brain Bank criteria
  • To be treated with antiparkinson

Exclusion Criteria:

  • Dementia
  • Severe cognitive impairment
  • Not willing to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03779880


Locations
Turkey
Istanbul Cerrahpaşa University
Istanbul, Turkey
Sponsors and Collaborators
Istanbul Kültür University
Marmara University
Istanbul University
Investigators
Study Chair: Gamze Ertürk, GRAD ASST Istanbul Kültür University
Study Director: Semra Oğuz, ASST PROF Marmara University

Responsible Party: Gamze Ertürk, Research assistant, Istanbul Kültür University
ClinicalTrials.gov Identifier: NCT03779880     History of Changes
Other Study ID Numbers: 132
First Posted: December 19, 2018    Key Record Dates
Last Update Posted: January 10, 2019
Last Verified: January 2019

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Gamze Ertürk, Istanbul Kültür University:
Parkinson Disease, Early Retirement,

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases